Study: NCT04236778

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VE303
Description: The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral Vancomycin
Description: Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.